Pollen Hayfever Immunotherapy (SLIT or SCIT) - UK Summer 2026

Pollen immunotherapy offers fantastic benefits!

It helps reshape the disease process toward long-term tolerance, prevents allergic rhinitis from progressing to asthma, reduces new allergies, and continues to provide relief even after treatment ends. Additionally, it improves symptom control while reducing reliance on medications. Isn’t that amazing?

---

Tell me more about pollen Immunotherapy:

If your child’s previous summer seasons were troublesome, with insufficient relief provided by frontline medications such as non-sedating antihistamines and nasal sprays, please consider initiating immunotherapy, namely SLIT (Sublingual Immunotherapy) or SCIT (Subcutaneous Immunotherapy).

Pollen immunotherapy is a type of treatment for hay fever (allergic rhinitis) that involves administering specific aeroallergens, such as grass and tree pollen, to build tolerance over time.

SLIT therapy can reduce hayfever symptoms and the need for medication and is typically recommended for those with moderate to severe allergies who have not had success with other treatments.

In some patients, immunotherapy can also help moderate Oral Allergy Syndrome symptoms and may delay the onset of allergic asthma symptoms in children.

Pollen Immunotherapy has advanced significantly since its discovery.

We use state-of-the-art SLIT and SCIT products. The products we use have been tested in multiple clinical trials involving more than 20,000 participants and have the largest evidence base of any AIT treatment. The MHRA has licensed products for use in the UK.

SLIT is taken daily, and the duration of therapy is typically three years. Children older than 6 years can usually tolerate allowing a tasteless tablet to dissolve under their tongue before swallowing it each day. SLIT can also be used to moderate allergic reactions to house dust mites or mould.

Immunotherapy works less well against animal dander due to the complexity of the allergens.

Is SCIT to pollen also available at London Allergy Consultants?

Yes, we do offer SCIT. We provide this within our ACE Service.

Subcutaneous immunotherapy (SCIT) for pollen allergens is an evidence-based treatment for allergic rhinitis and asthma, in which graded doses of allergen extracts are administered to induce immunological tolerance and reduce symptoms. SCIT is recommended as an adjunct for patients with confirmed allergic sensitisation and symptoms not adequately controlled by standard therapy.

SCIT has demonstrated reductions in symptom scores and medication requirements, and improvements in quality of life, with long-term benefits persisting after discontinuation.

Local injection site reactions are common, while systemic reactions occur less frequently; poorly controlled asthma is a major risk factor for severe adverse events. SCIT should not be administered at home and requires a formal assessment of allergic sensitisation prior to initiation.

Frequently Asked Questions

• How to access pollen Immunotherapy on the NHS

  Important Realities of NHS Access

  Timing: For pollen allergies, treatment usually needs to start in the autumn or winter (October–December) so that your body is prepared before the spring pollen season begins. It may therefore be too late to set up a pathway for the summer of 2026.

  Availability on the NHS: Access is "postcode dependent." Some Integrated Care Boards (ICBs) have stricter funding criteria than others.

  You will need to ask your GP to refer you to your nearest NHS clinic, for clinics that do provide immunotherapy please check - the BSACI (British Society for Allergy & Clinical Immunology) Clinic Finder to see where your nearest NHS specialist allergy service is located.

• How to access Pollen Immunotherapy in Private Practice in London, UK

  At London Allergy Consultants, we are proud to be one of the UK’s largest and most experienced providers of pollen immunotherapy for children.

  Our team has been at the forefront of this field for years, not only in private practice but through long-standing leadership and clinical involvement within the NHS.

  We understand that severe hay fever is more than just a seasonal nuisance—it can impact a child’s schooling, sleep, and overall quality of life. Because we have extensive experience in initiating and managing ongoing care across a wide range of treatment options, we are able to provide a highly personalized approach for every family.

• Do i/we choose SLIT or SCIT?

  Logistical considerations may apply:

  Different licenses may apply

  Patients may be needle phobic, SLIT will suit them better

  Patients my be more unlikely to follow a daily regimen, SCIT will suit them better

  Efficacy:

  SCIT and SLIT are both effective for pollen allergies, with most comparative trials showing similar reductions in symptom and medication scores for both modalities.

  SCIT may demonstrate earlier onset of efficacy and, in some studies, slightly greater clinical benefit, but the majority of head-to-head trials are underpowered and do not show statistically significant differences between SCIT and SLIT for pollen allergy endpoints.

  SCIT is associated with a higher risk of systemic reactions, including rare but potentially severe anaphylaxis, whereas SLIT has a lower prevalence of systemic reactions and is generally considered safer, allowing for daily home administration without direct physician oversight.

  Local reactions are common with both, but systemic reactions are more frequent with SCIT.

  The choice between SCIT and SLIT should be individualized, taking into account efficacy, safety profile, patient preference, and logistical considerations. We will discuss this all in detail during your assessment cisits in our London Allergy Consultant clinics.

• How can we get Pollen Allergy Tests in the UK

  Please book an appointment in clinic.

  Ideally this will be face-to-face, we can then perform SPT and if needed blood testing.

  If this is not possible, we are happy to perform remote Zoom appointments, and home blood testing using the ALEX3 test can be set up by our office.

  WE can then discuss treatment and product options and how best, and safest, to commece treatment.

• Is SLIT and SCIT a safe form of therapy?

  Sublingual immunotherapy is safer than subcutaneous immunotherapy for the treatment of hay fever (allergic rhinitis), with most adverse reactions being mild, transient, and limited to local oral or gastrointestinal symptoms such as itching or dyspepsia; severe systemic reactions and anaphylaxis are exceedingly rare and have not been reported in large randomised controlled trials or systematic reviews.

  Sublingual immunotherapy can be administered at home after the first supervised dose, and does not require emergency preparedness for systemic reactions.

  Subcutaneous immunotherapy carries a higher risk of systemic reactions, including rare but potentially life-threatening anaphylaxis, with a rate of approximately 0.1% per injection visit and one anaphylactic event per 160,000 injections; therefore, it must be administered in a medical setting with observation and access to emergency treatment.

  Most reactions are mild (local injection site reactions), but systemic hypersensitivity episodes are more frequent than with sublingual immunotherapy.

  Both modalities are effective, but the safety profile of sublingual immunotherapy is superior, making it preferable for patients at higher risk of systemic reactions or those seeking neele-free convenience.

• Which SLIT and SCIT products are licensed for use in the UK and what is the price?

  In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has licensed several products for both sublingual (under the tongue) and subcutaneous (injection) use.

  1. Sublingual Immunotherapy (SLIT)

  These are daily tablets or drops taken at home after the first dose is supervised by a specialist.

  Grazax

  ALK-Abelló

  Grass Pollen (Timothy Grass)

  5 to 65 years

  Itulazax

  ALK-AbellóTree Pollen (Birch, Alder, Hazel)

  18 to 65 years

  Acarizax

  ALK-Abelló

  House Dust Mite

  12 to 65 years

  2. Subcutaneous Immunotherapy (SCIT)

  These are injections ("allergy shots") administered by a specialist in a clinic with resuscitation facilities.

  Allergy Therapeutics

  Grass Pollen

  6 years and over

  Pollinex Tree

  Allergy Therapeutics

  Tree Pollen

  6 years and over

  Alutard SQ

  ALK-AbellóGrass, Tree, or Dust Mite

  5 years and over

• Featured Research by Prof Du Toit and Dr Foong re the topic of pollen allergies and associated hayfever and the oral allergy syndrome

  Pollen, Food Allergy, and Hay Fever

  Diagnosis and Management of Pollen Food Allergy Syndrome to Nuts (2024)

  • Journal: The Journal of Allergy and Clinical Immunology: In Practice

  • Contribution: This clinical framework helps clinicians distinguish between a life-threatening primary nut allergy and Pollen Food Allergy Syndrome (PFAS). It provides clarity on when patients with hay fever can safely consume certain nuts (like hazelnuts or almonds) if they are processed or heated, which typically destroys the pollen-like proteins.

  EAACI Guidelines on the Diagnosis of IgE-mediated Food Allergy (2023)

  • Journal: Allergy

  • Contribution: These international guidelines define the use of Component Resolved Diagnostics (CRD). This breakthrough technology allows doctors to see if a patient is reacting to "pollen-mimicking" proteins (often causing mild hay fever-related symptoms) or stable "storage proteins" that carry a higher risk of severe allergic reactions.

  BSACI Guideline for the Diagnosis and Management of Pollen Food Syndrome in the UK (2022)

  • Journal: Clinical & Experimental Allergy

  • Contribution: Dr. Foong and Prof. Du Toit contributed to this essential UK roadmap for managing Pollen Food Syndrome (PFS). It offers practical advice for patients who experience an itchy mouth or throat after eating raw fruits or vegetables due to their underlying hay fever.

  Asthma, Food Allergy, and How They Relate to Each Other (2017)

  • Journal: Frontiers in Pediatrics

  • Contribution: A seminal review of the "Allergic March." This paper details how early-onset hay fever and pollen sensitization can be early warning signs that influence the severity of a child’s asthma and their risk profile for developing multiple food allergies.

  EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis (2017)

  • Journal: Allergy

  • Contribution: Prof. Du Toit co-authored these foundational guidelines confirming that Allergen Immunotherapy (AIT)—such as sublingual hay fever drops—is a disease-modifying treatment. It doesn't just mask symptoms; it retrains the immune system to tolerate pollen, which can significantly improve a patient’s overall quality of life.

  Pollen Food Syndrome amongst Children with Seasonal Allergic Rhinitis (2015)

  • Journal: Pediatric Allergy and Immunology

  • Contribution: This study was one of the first to highlight how common Pollen Food Syndrome is in children with hay fever. It showed that as children get older, their hay fever frequently leads to new reactions to raw fruits and nuts, identifying a clear need for early screening in allergy clinics.

Worried About Allergies? Let’s Help You Get Answers

If your child is showing signs of a food, pollen, or skin allergy, early diagnosis is key. At London Allergy Consultants, our expert team provides trusted, evidence-based care tailored to your child’s needs. From testing to treatment plans, we guide you every step of the way.

London Allergy Consultants

London Allergy Consultants is a leading UK centre for diagnosing and treating food and airborne allergies in children and young people.

Get in Touch

07754050302 , 07754050303

office@londonallergyconsultants.com